Your session is about to expire
← Back to Search
Probiotic
Greek Yogurt for Osteoporosis and Inflammation
N/A
Waitlist Available
Research Sponsored by Brock University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults 55+ years from the Niagara area
Be older than 18 years old
Must not have
Diagnosed with lactose intolerance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 0 and 8
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to see if eating Greek yogurt and doing regular exercise can improve bone health and reduce inflammation in older adults. They will compare a group that eats Greek yogurt and exercises, a group that only
Who is the study for?
This trial is for senior adults interested in the potential health benefits of Greek yogurt. Participants should be experiencing inflammation or osteoporosis and willing to consume Greek yogurt regularly. They must also be open to participating with or without accompanying regular exercise.
What is being tested?
The study tests if eating Greek yogurt can improve bone metabolism and reduce inflammation in seniors, comparing groups who exercise (GYEX), don't exercise (GYNE), and a control group that only exercises without yogurt (NYEX).
What are the potential side effects?
Greek yogurt is generally safe but may cause digestive discomfort, such as bloating or gas, especially in those with lactose intolerance or dairy sensitivity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 55 years old or older and live in the Niagara area.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with lactose intolerance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 0 and 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 0 and 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Plasma concentrations of interleukin-10 (IL10)
Plasma concentrations of interleukin-6 (IL6)
Serum concentrations of C-telopeptides of type I collagen (CTX)
+9 moreSecondary study objectives
Body composition
Body mass
Energy intake and expenditure
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Greek yogurt exercising group (GYEX)Experimental Treatment1 Intervention
Participants will be asked to consume 2 servings/day (preferably morning and night) of 175 g commercially available GY (0% MF, flavoured, 130 calories, 17 g protein, 225 g calcium (e.g., OIKOS High Protein GY) for a total of 8 weeks. For their convenience, the participants will be provided with appropriate scoops to measure out 175 g of GY per serving of the larger 650 g commercially available, pre-packaged containers. Although it is recommended to consume the two servings morning and night, to increase ecological validity and strengthen the feasibility of the intervention, the timing of the servings will be flexible to facilitate daily routines and lifestyles. For the same reasons, the participants will be able to choose the flavour of their GY.
Group II: Control exercising group (NYEX)Active Control1 Intervention
During the 8-weeks, participants will be instructed to follow their typical, habitual diet and exercise regimen.
Group III: Intervention non-exercising group (GYNE)Active Control1 Intervention
Participants will be instructed to follow their typical habitual diet. Participants will be asked to consume 2 servings/day (preferably morning and night) of 175 g commercially available GY (0% MF, flavoured, 130 calories, 17 g protein, 225 g calcium; e.g., OIKOS High Protein GY) for a total of 8 weeks. For their convenience, the participants will be provided with appropriate scoops to measure out 175 g of GY per serving of the larger 650 g commercially available, pre-packaged containers. Although it is recommended to consume the two servings morning and night, to increase ecological validity and strengthen the intervention's feasibility, the servings' timing will be flexible to facilitate daily routines and lifestyles. For the same reasons, the participants will be able to choose the flavour of their GY.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Greek yogurt
2011
N/A
~60
Find a Location
Who is running the clinical trial?
Brock UniversityLead Sponsor
40 Previous Clinical Trials
6,479 Total Patients Enrolled